Mike Rothe
Director Ejecutivo en IBA GmbH .
Origen de la red de primer grado Mike Rothe.
Entidad | Tipo de entidad | Industria | |
---|---|---|---|
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA.
15
| Extinct | Miscellaneous Commercial Services | 15 |
IBA GmbH
IBA GmbH Medical/Nursing ServicesHealth Services IBA GmbH provides product and service solutions for life science research. Its product and service portfolio includes cell selection and expansion, cloning, transfection, recombinant protein production and assays to nucleic acid custom services. The company was founded in 1999 and is headquartered in Göttingen, Germany.
5
| Private Company | Medical/Nursing Services | 5 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Mike Rothe a través de su red personal
Empresa | Sector | Personas relacionadas | Puesto principal |
---|---|---|---|
AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal General Counsel Consultant / Advisor | |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
STANDARD BIOTOOLS INC. | Medical Specialties | Director/Board Member | |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Director/Board Member | |
CHEMOCENTRYX, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
GENOMIC HEALTH, INC. | Medical Specialties | Director/Board Member | |
NGM BIOPHARMACEUTICALS, INC. | Biotechnology | Chairman Chief Tech/Sci/R&D Officer | |
Spirox, Inc.
Spirox, Inc. Medical SpecialtiesHealth Technology Spirox, Inc. develops medical devices. Its product LATERA Absorbable Nasal Implant is designed to address causes of nasal obstruction today, nasal valve collapse caused by weakened lateral wall cartilage. The company was founded by Donald Albert Gonzales and Iyad Saidi on November 3, 2011 and is headquartered in Menlo Park, CA. | Medical Specialties | Director/Board Member | |
MPM BioImpact, Inc
MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor | |
University of Freiburg | College/University | Corporate Officer/Principal | |
Parke-Davis & Co. Ltd.
Parke-Davis & Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Parke-Davis & Co. Ltd. is a British pharmaceutical company. The company is based in St. Helier, UK. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Amgen Research (Munich) GmbH
Amgen Research (Munich) GmbH Metal FabricationProducer Manufacturing Part of Amgen, Inc., Amgen Research (Munich) GmbH is a biotechnology company based in Munich, Germany. The company has over 850 employees working at two locations in Germany. Amgen Scholars Europe Programs offer practical research experience to 100 students from all over Europe every summer. The company utilizes biotechnological possibilities to develop innovative treatments for diseases. The company continuously develops new substances to provide biopharmaceuticals to patients worldwide with serious illnesses. The CEOs of the company are Peter Kufer and Robert Saller. Amgen Research (Munich was acquired by ECKA Granulate GmbH & Co. KG from Aurubis AG on June 13, 2002. | Metal Fabrication | Chief Tech/Sci/R&D Officer | |
University of Michigan | College/University | Doctorate Degree | |
TeGenero AG
TeGenero AG Pharmaceuticals: MajorHealth Technology TeGenero AG discovers and develops novel therapeutics. It is a biopharmaceutical company providing services in the identification and development of effective and applicable therapeutics for the treatment of severe immunological disorders. It's first development candidate TGN1412, a SuperMAB with specificity for the T cell surface receptor CD28 is in non-clinical development. Clinical applications of SuperMAB and its derived compounds are expected to solve unmet medical needs in the fields of cancer-related immunodeficiencies such as B-cell chronic lymphocytic leukaemia and autoimmune/inflammatory diseases like rheumatoid arthritis. The company was founded in 2000 and is headquartered in Wurzburg, Germany. | Pharmaceuticals: Major | Director/Board Member | |
Universidad Complutense de Madrid | College/University | Undergraduate Degree | |
Max-Planck-Institute for Molecular Genetics | College/University | Doctorate Degree | |
Amgen Rockville, Inc.
Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Ludwig-Maximilians-Universität München | College/University | Doctorate Degree | |
The United States Olympic Endowment
The United States Olympic Endowment Investment Trusts/Mutual FundsMiscellaneous The United States Olympic Endowment is an independent nonprofit company that creates as an endowment for sports in the Olympic Movement in the United States. The company was founded in 1984 and is headquartered in Colorado Springs, CO. | Investment Trusts/Mutual Funds | Director/Board Member | |
European Molecular Biology Organization | Corporate Officer/Principal | ||
The Column Group LLC
The Column Group LLC Investment ManagersFinance The Column Group LLC is a venture capital firm founded in 2005 by Peter Svennilson. The firm is headquartered in San Francisco. | Investment Managers | Private Equity Investor Human Resources Officer | |
Mission Bay Capital Management, Inc.
Mission Bay Capital Management, Inc. Investment ManagersFinance Mission Bay Capital Management Inc (Mission Bay Capital) is a venture capital firm founded in 2009. The firm is headquartered in San Francisco, California. | Investment Managers | Consultant / Advisor | |
Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
LMNVC LLC
LMNVC LLC Investment ManagersFinance LMNVC LLC (LMNVC) is a venture capital firm founded in 2010 by Corinne Nevinny, Margot Sherr Shapiro, and Linda Greub. The firm is headquartered in Beverly Hills, California. | Investment Managers | Founder | |
Corvidia Therapeutics, Inc.
Corvidia Therapeutics, Inc. BiotechnologyHealth Technology Corvidia Therapeutics, Inc. is a biotechnology company focusing on cardiovascular therapies. It develops treatments for atherosclerotic cardiovascular disease, inflammation in chronic kidney diseases, and high triglyceride-induced acute pancreatitis. The company was founded by Michael H. Davidson, Rahul Kakkar, Matt Devalaraja, and Ram Aiyar in 2015 and is headquartered in Waltham, MA. | Biotechnology | Director/Board Member | |
UNITY BIOTECHNOLOGY, INC. | Biotechnology | Director/Board Member | |
HARPOON THERAPEUTICS, INC. | Biotechnology | Founder | |
RAPT THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman President | |
ARCUS BIOSCIENCES, INC. | Biotechnology | Director/Board Member Founder | |
iOmx Therapeutics AG
iOmx Therapeutics AG BiotechnologyHealth Technology iOmx Therapeutics AG develops immunotherapy treatments for cancer patients. It specializes in immuno oncology, drug development and cancer therapy. The company was founded by Nisit Khandelwal, Philipp Beckhove, Patrick Baeuerle, Sebastian Meier-Ewert and Elmar Maier in March 2016 and is headquartered in Munich, Germany. | Biotechnology | Founder | |
TCR2 THERAPEUTICS INC. | Pharmaceuticals: Major | Founder | |
Maverick Therapeutics, Inc.
Maverick Therapeutics, Inc. BiotechnologyHealth Technology Maverick Therapeutics, Inc. operates as a preclinical stage biotech company. It develops a novel class of T cell- redirecting antibody therapeutics that have the potential to substantially broaden the range of targets and clinical applications to be used for this ultra-potent mechanism. The company was founded by Robert Dubridge and Patrick A. Baeuerle in 2016 and is headquartered in Brisbane, CA. | Biotechnology | Founder | |
R2M Pharma, Inc.
R2M Pharma, Inc. BiotechnologyHealth Technology R2M Pharma, Inc. develops, discovers, and manufactures pharmaceutical products. The private company is based in San Francisco, CA. | Biotechnology | Director/Board Member | |
Biolux Research Holdings, Inc.
Biolux Research Holdings, Inc. Medical/Nursing ServicesHealth Services Biolux Research Holdings, Inc. engages in healthcare services. The company is headquartered in Pleasanton, CA. | Medical/Nursing Services | Director/Board Member | |
WEREWOLF THERAPEUTICS, INC. | Pharmaceuticals: Major | Founder | |
Avestria Ventures Management, LLC
Avestria Ventures Management, LLC Investment ManagersFinance Avestria Ventures Management LLC (Avestria Ventures) is a venture capital firm founded in 2018 by Linda M. Greub and Corinne H. Nevinny. The firm is headquartered in San Francisco, California. | Investment Managers | Founder | |
CULLINAN THERAPEUTICS, INC. | Pharmaceuticals: Major | Founder | |
HBS Global Properties LLC
HBS Global Properties LLC Real Estate DevelopmentFinance HBS Global Properties LLC is an American company that specializes in the development, brokerage, and management of residential and commercial properties. The private company is based in New York. | Real Estate Development | Consultant / Advisor | |
Ocelot Bio, Inc.
Ocelot Bio, Inc. Pharmaceuticals: MajorHealth Technology Ocelot Bio, Inc. is a clinical-stage biopharmaceutical company that focuses on improving outcomes for patients with end-stage liver disease (ESLD), particularly those suffering from hepatorenal syndrome with acute kidney injury (HRS-AKI) and refractory ascites. The company is based in San Diego, CA. The company is developing therapeutic peptides to treat complications of decompensated cirrhosis, a condition in which the liver is scarred and permanently damaged, leading to liver failure. HRS-AKI is a life-threatening consequence of portal hypertension, which causes a significant drop in arterial pressure and renal perfusion. Ocelot Bio is in early-stage development of OCE-205 for the treatment of ascites, a complication of ESLD-induced portal hypertension that leads to the accumulation of fluid in the peritoneal cavity. The company was founded by Geoffrey Harris, and Katherine Vega Stultz has been the CEO of the company since 2022. | Pharmaceuticals: Major | Director/Board Member | |
Mahzi Therapeutics, Inc.
Mahzi Therapeutics, Inc. BiotechnologyHealth Technology Mahzi Therapeutics is a private biotechnology company that focuses on genetic therapies for rare genetic neurodevelopmental disorders. The company was founded by Yael Weiss and is based in San Mateo, CA. The company unites patient and family groups, academic researchers, diagnostic companies, other industry members, and its internal team of experts to develop therapies for patients with these serious diseases. Mahzi's team is experienced in all aspects of biopharmaceutical research, development, and manufacturing and is driven to make a difference in the lives of patients with rare genetic diseases. Yael Weiss has been the CEO since incorporation. | Biotechnology | Director/Board Member | |
Crossbow Therapeutics, Inc.
Crossbow Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Crossbow Therapeutics, Inc. is a biotechnology company that aims to improve the lives of people with cancer by developing next-generation immunotherapies. The company is based in Cambridge, MA, and the CEO of the company is Briggs W. Morrison. The company's T-bolt™ therapies are designed to target previously unreachable cancer cell targets with high precision. Crossbow's approach is efficient and selective, allowing them to target the entire universe of cancer proteins, which expands the potential of antibody therapy to address many types of cancer. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer |
Estadísticas
Internacional
Estados Unidos | 40 |
Alemania | 9 |
Suiza | 2 |
Reino Unido | 2 |
España | 2 |
Sectorial
Health Technology | 34 |
Finance | 8 |
Consumer Services | 7 |
Producer Manufacturing | 2 |
Miscellaneous | 2 |
Operativa
Director/Board Member | 75 |
Corporate Officer/Principal | 41 |
Independent Dir/Board Member | 21 |
Founder | 17 |
Chief Tech/Sci/R&D Officer | 15 |
Las relaciones más conectadas
Insiders | |
---|---|
Camille Samuels | 30 |
Patrick Baeuerle | 19 |
Corinne Nevinny | 19 |
John McLaughlin | 17 |
William Rieflin | 16 |
Juan Jaen | 16 |
Yasunori Kaneko | 13 |
Marshall P. Levine | 12 |
Julia C. Owens | 10 |
James M. Gower | 8 |
Hui Tian | 6 |
Carla Daniel | 6 |
Casey C. Case | 6 |
Pieter B. M. W. M. Timmermans | 5 |
Chris Smith | 3 |
- Bolsa de valores
- Insiders
- Mike Rothe
- Conexiones Empresas